FI101625B1 - Complex Suitable for Implementing a Procedure for Purification of Pre-S Hepatitis B Virus Surface Antigen - Google Patents
Complex Suitable for Implementing a Procedure for Purification of Pre-S Hepatitis B Virus Surface AntigenInfo
- Publication number
- FI101625B1 FI101625B1 FI904412A FI904412A FI101625B1 FI 101625 B1 FI101625 B1 FI 101625B1 FI 904412 A FI904412 A FI 904412A FI 904412 A FI904412 A FI 904412A FI 101625 B1 FI101625 B1 FI 101625B1
- Authority
- FI
- Finland
- Prior art keywords
- hepatitis
- surface antigen
- virus surface
- purification
- implementing
- Prior art date
Links
- 241000700721 Hepatitis B virus Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 238000000746 purification Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 102000008100 Human Serum Albumin Human genes 0.000 abstract 2
- 108091006905 Human Serum Albumin Proteins 0.000 abstract 2
- 238000001042 affinity chromatography Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a complex consisting of an insoluble polymeric support to which monomeric human albumin is covalently bonded, and of a pre-S hepatitis B virus surface antigen which is bound via its pre-S(2) and/or pre-S(1) part to the monomeric human albumin in a form which can be eluted. This complex can be used for therapeutic and diagnostic purposes and allows rapid and efficient purification of pre-S HBsAg by affinity chromatography.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT219889 | 1989-09-20 | ||
AT2198/89A AT392417B (en) | 1989-09-20 | 1989-09-20 | COMPLEXLY SUITABLE FOR PERFORMING A METHOD FOR CLEANING PRE-S-HEPATITIS-B-VIRUS SURFACE ANTIGENS |
Publications (3)
Publication Number | Publication Date |
---|---|
FI904412A0 FI904412A0 (en) | 1990-09-07 |
FI101625B FI101625B (en) | 1998-07-31 |
FI101625B1 true FI101625B1 (en) | 1998-07-31 |
Family
ID=3529817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI904412A FI101625B1 (en) | 1989-09-20 | 1990-09-07 | Complex Suitable for Implementing a Procedure for Purification of Pre-S Hepatitis B Virus Surface Antigen |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0419446B1 (en) |
JP (1) | JP2721033B2 (en) |
AT (2) | AT392417B (en) |
CA (1) | CA2025263A1 (en) |
DE (1) | DE59008927D1 (en) |
DK (1) | DK0419446T3 (en) |
ES (1) | ES2074558T3 (en) |
FI (1) | FI101625B1 (en) |
NO (1) | NO300421B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111659355B (en) * | 2020-06-23 | 2022-12-13 | 武汉瑞法医疗器械有限公司 | Alkylation modified hepatitis B virus immunoadsorbent and preparation method thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL45247A0 (en) * | 1974-07-11 | 1974-10-22 | Yeda Res & Dev | Water insoluble protein preparations |
US4515714A (en) * | 1983-03-09 | 1985-05-07 | Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute | Method for purification of hepatitis B virus surface antigen |
ATE73349T1 (en) * | 1984-06-18 | 1992-03-15 | Chiron Corp | HEPATITIS SURFACE ANTIGEN PARTICLE VACCINATION. |
JPS6137738A (en) * | 1984-07-31 | 1986-02-22 | Tetsuo Nakamura | Vaccine for hepatitis b |
EP0243103B1 (en) * | 1986-04-25 | 1992-12-30 | Merck & Co. Inc. | Purification of pre-s hbsag by polymerized serum albumin affinity binding |
US4855055A (en) * | 1988-09-28 | 1989-08-08 | National Science Council | Isolation and purification pre-S2 containing hepatitis B virus surface antigen by chemical affinity chromatography |
-
1989
- 1989-09-20 AT AT2198/89A patent/AT392417B/en not_active IP Right Cessation
-
1990
- 1990-09-07 FI FI904412A patent/FI101625B1/en not_active IP Right Cessation
- 1990-09-13 EP EP90890262A patent/EP0419446B1/en not_active Expired - Lifetime
- 1990-09-13 DE DE59008927T patent/DE59008927D1/en not_active Expired - Fee Related
- 1990-09-13 DK DK90890262.0T patent/DK0419446T3/en active
- 1990-09-13 CA CA002025263A patent/CA2025263A1/en not_active Abandoned
- 1990-09-13 AT AT90890262T patent/ATE121417T1/en not_active IP Right Cessation
- 1990-09-13 ES ES90890262T patent/ES2074558T3/en not_active Expired - Lifetime
- 1990-09-19 NO NO904085A patent/NO300421B1/en not_active IP Right Cessation
- 1990-09-20 JP JP2254023A patent/JP2721033B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO904085D0 (en) | 1990-09-19 |
FI904412A0 (en) | 1990-09-07 |
FI101625B (en) | 1998-07-31 |
EP0419446A1 (en) | 1991-03-27 |
DK0419446T3 (en) | 1995-08-28 |
JPH03120300A (en) | 1991-05-22 |
NO300421B1 (en) | 1997-05-26 |
AT392417B (en) | 1991-03-25 |
DE59008927D1 (en) | 1995-05-24 |
ES2074558T3 (en) | 1995-09-16 |
ATA219889A (en) | 1990-09-15 |
EP0419446B1 (en) | 1995-04-19 |
CA2025263A1 (en) | 1991-03-21 |
NO904085L (en) | 1991-03-21 |
ATE121417T1 (en) | 1995-05-15 |
JP2721033B2 (en) | 1998-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU90911I2 (en) | Recombinant antigen comprising the pre-S1 and S sequences of the hepatitis B virus active ingredient of hepacare | |
US4113712A (en) | HBsAG Particle composed of single polypeptide subunits and the preparation procedure | |
ATE139122T1 (en) | MHC-SUPPORTED CONJUGATES FOR USE IN BOOSTING AUTO-IMMUNITY | |
FI884993A0 (en) | POLYPEPTIDER. | |
ITMI931522A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION (HBV) | |
PT86640A (en) | HEPATITIS B VIRUS SURFACE ANTIGENS AND HYBRID ANTIGENS CONTAINING THEM | |
DK235289D0 (en) | EXPRESSION OF HAPATITIS B S AND PRAES2 PROTEINS IN METHYLOTROPHIC GAERTS | |
HU9301794D0 (en) | Medical preparative for treating chronical viral diseases of liver as well qs method for preparing said medicament | |
EP0687182A4 (en) | Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus | |
FI101625B1 (en) | Complex Suitable for Implementing a Procedure for Purification of Pre-S Hepatitis B Virus Surface Antigen | |
FR2689398B1 (en) | Compositions for the treatment of hepatitis B virus (HBV) infection and diseases. | |
NZ219516A (en) | Fusion proteins of hbcag (hepatitis b virus core antigen) | |
FR2696748B1 (en) | Process for the preparation of hepatitis A antigens and vaccines (HAV). | |
DE69130724D1 (en) | Process for obtaining recombinant hepatitis B virus (HEP B) surface antigen | |
EP0243103A3 (en) | Purification of pre-s hbsag by polymerized serum albumin affinity binding | |
EP0414816A4 (en) | Induction of tolerance to a foreign antigen | |
KR890701743A (en) | Hepatitis B surface antigen vaccine | |
EP0175269A3 (en) | Immunogen conjugates and the use thereof in a dihydropyridine assay | |
EP0542753A4 (en) | Epitopes of the pre-s region of hepatitis b virus surface antigen | |
FR2486802B1 (en) | PURIFICATION OF HEPATITIS B SURFACE ANTIGEN (HBSAG) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Owner name: IMMUNO AKTIENGESELLSCHAFT |
|
MA | Patent expired |